Business Wire

CO-NEWMONT-CORP

14.4.2022 17:02:12 CEST | Business Wire | Press release

Share
Newmont Publishes 2021 Sustainability Report

Today, Newmont Corporation (NYSE: NEM, TSX: NGT) launched its 2021 Sustainability Report as part of its suite of reports on the Company’s environmental, social and governance (ESG) practices in key areas that include health, safety and security, human rights, the environment, social acceptance, governance, and inclusion and diversity.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220414005599/en/

“Newmont has a long tradition of setting and transparently reporting against public targets. With this report, we offer stakeholders a clear and comprehensive understanding of our most material sustainability topics,” said Tom Palmer, Newmont President and CEO. “As the world’s leading gold company, our ESG practices are woven into the fabric of our company as we work to deliver on our purpose: to create value and improve lives through sustainable and responsible mining.”

Highlights of Newmont’s 2021 Sustainability Report:

  • Commitment to health and safety: Achieved zero work-related fatalities for the third year in a row. Further embedded our Fatality Risk Management program with a focus on verifying the critical controls that prevent fatalities and coaching frontline leaders to provide visible, felt leadership.
  • Response to COVID-19: Continued to put the health, safety and wellbeing of our workforce and host communities at the heart of every decision the Company made. Newmont strongly supported COVID-19 vaccines as they became available and adopted the position of requiring all employees and third-party workers to be fully vaccinated. With contributions through Newmont’s Global Community Support Fund, the Company supported COVID-19 testing facilities, vaccine awareness campaigns and vaccine rollouts in areas near our operations.
  • Sustainability-linked financial performance: Established the industry’s first sustainability-linked bond, holding Newmont to account for meeting our 2030 emissions reductions targets and to achieve gender parity in senior leadership roles by 2030. This represents the next step in aligning our business to our commitments and values by linking the interest rate payout to our performance on key ESG priorities.
  • Value sharing: Newmont played an important role in creating economic value in host communities and jurisdictions, contributing $10.8 billion to its workforce, host communities and jurisdictions through wages and benefits, operating costs, capital spend, royalties and taxes. This includes spending $1.4 billion with local and Indigenous suppliers, $21.9 million in community investments and providing ongoing opportunities for local and Indigenous employment, along with an additional $3.5 million from Newmont’s Global Community Support Fund.

Newmont’s sustainability efforts continue to be recognized by several leading independent organizations:

  • Recognized as a leading gold miner for the seventh consecutive year in the Dow Jones Sustainability Index (DJSI) while continuing to be ranked as the top mining company on FORTUNE’s list of the World’s Most Admired Companies;
  • Earned a rating of “AA” from MSCI, putting Newmont in the top quartile for precious metals and mining;
  • Listed as sixth overall and the top mining company in 3BL’s 100 Best Corporate Citizens;
  • Included in Bloomberg’s Gender-Equality Index (GEI) for Newmont’s efforts to advance women in the workplace for the fourth successive year;
  • Named to the JUST 100 as one of America’s most JUST companies by JUST Capital and CNBC, included in the JUST 100 and named Industry Leader for 2022; and
  • One of the most transparent companies in the S&P 500, according to Bloomberg’s ESG Disclosure Score.

Newmont’s 2021 Sustainability Report is written in accordance with the GRI 2016 Universal Standards Core option, the GRI Mining and Metals Sector Supplement, the Sustainability Accounting Standards Board (SASB) Metals and Mining standards and is externally assured by an independent third-party. Additionally, Newmont’s sustainability report aligns with ICMM’s Mining Principles’ Performance Expectations and the World Gold Council’s Responsible Gold Mining Principles.

The full 2021 Sustainability Report, along with the ESG data tables and comprehensive GRI and SASB content indices, is available for download on Newmont’s website .

About Newmont

Newmont is the world’s leading gold company and a producer of copper, silver, zinc and lead. The Company’s world-class portfolio of assets, prospects and talent is anchored in favorable mining jurisdictions in North America, South America, Australia and Africa. Newmont is the only gold producer listed in the S&P 500 Index and is widely recognized for its principled environmental, social and governance practices. The Company is an industry leader in value creation, supported by robust safety standards, superior execution and technical expertise. Newmont was founded in 1921 and has been publicly traded since 1925.

At Newmont, our purpose is to create value and improve lives through sustainable and responsible mining. To learn more about Newmont’s sustainability strategy and initiatives, go to www.newmont.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release

As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release

Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release

Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release

Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye